- Home
- FLOC vs FDMT Comparison
FLOC vs FDMT Comparison
Compare FLOC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLOC | FDMT |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | 1281 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.3M | 515.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FLOC | FDMT |
|---|---|---|
| Price | $23.76 | $9.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $28.50 | ★ $31.71 |
| AVG Volume (30 Days) | ★ 946.7K | 755.3K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.34% | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | $22.92 | N/A |
| Revenue Next Year | $8.59 | $70.28 |
| P/E Ratio | $16.57 | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $14.03 | $2.89 |
| 52 Week High | $24.91 | $12.34 |
Technical Indicators
Market Signals| Indicator | FLOC | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 61.10 | 52.29 |
| Support Level | $15.04 | $8.41 |
| Resistance Level | $24.26 | $10.19 |
| Average True Range (ATR) | 0.96 | 0.69 |
| MACD | 0.30 | 0.03 |
| Stochastic Oscillator | 84.99 | 49.59 |
Price Performance
Historical ComparisonAbout FLOC Flowco Holdings Inc.
Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).